Self-Managed Medication Abortion: Implications for Clinical Practice
- 12 December 2022
- journal article
- research article
- Published by SAGE Publications in The Linacre Quarterly
- Vol. 90 (3), 273-289
- https://doi.org/10.1177/00243639221128389
Abstract
Medication abortion represents more than 50 percent of abortions in the United States (US). Since its approval in the US in 2000, the Food and Drug Administration (FDA) has progressively relaxed the prescribing requirements such that currently, no office visit, in-person dispensing, or ultrasound is required. Obtaining medication for abortion online without medical supervision or evaluation is also possible. This article reviews the complications of medication abortion by examining major studies and delineates the risks specific to self-managed abortion to inform clinicians in caring for women. Summary: Medication abortion has become the most common abortion method in the United States. This document provides a detailed history of the relaxation requirements on medication abortion and reviews the major studies on medication abortion complications including a discussion of their limitations. Finally, the paper delineates the ease of access to medication abortion without a health care provider and the risks associated with self-managed abortion. This paper is intended to provide information for clinicians who likely will be encountering increasing number of patients with such complications.Keywords
This publication has 39 references indexed in Scilit:
- Birth defects after exposure to misoprostol in the first trimester of pregnancy: Prospective follow-up studyReproductive Toxicology, 2013
- Management of postabortion hemorrhageContraception, 2013
- First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic reviewContraception, 2013
- Immediate adverse events after second trimester medical termination of pregnancy: results of a nationwide registry studyHuman Reproduction, 2011
- The global burden of Rh diseaseArchives of Disease in Childhood: Fetal & Neonatal, 2010
- Immediate Complications After Medical Compared With Surgical Termination of PregnancyObstetrics & Gynecology, 2009
- Analysis of Severe Adverse Events Related to the Use of Mifepristone as an AbortifacientAnnals of Pharmacotherapy, 2006
- Pathophysiology of Mifepristone-Induced Septic Shock Due toClostridium sordelliiAnnals of Pharmacotherapy, 2005
- First trimester ultrasound screening is effective in reducing postterm labor induction rates: A randomized controlled trialAmerican Journal of Obstetrics and Gynecology, 2004
- Risk Factors for Legal Induced Abortion–Related Mortality in the United StatesObstetrics & Gynecology, 2004